Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed Nov 21, 2025

Accession no.
0001193125-25-291590
Filed
Nov 21, 2025, 5:07 PM ET
Trade date
Nov 21, 2025
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 5 non-derivative transactions. Open-market purchases total $768.8K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 21, 2025Common StockPPurchaseAcquired+102,371$1.30+$133,082.3216,228,819Indirect
Nov 21, 2025Common StockPPurchaseAcquired+3,894$1.32+$5,140.08216,232,713Indirect
Nov 21, 2025Common StockPPurchaseAcquired+89,375$1.33+$118,421.88216,322,088Indirect
Nov 21, 2025Common StockPPurchaseAcquired+191,490$1.33+$254,681.7216,513,578Indirect
Nov 21, 2025Common StockPPurchaseAcquired+192,870$1.34+$257,481.45216,706,448Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)